Contact: Caroline Arbanas
Washington University School of Medicine
Caption: By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Washington University scientists Timothy Graubert, M.D., (left) and Matthew Walter, M.D., have found clues to suggest that targeted cancer drugs should be aimed at mutations that develop early in the disease.
Credit: Michael Purdy, Washington University
Usage Restrictions: Credit to Washington University
Related news release: Scientists map genetic evolution of leukemia